Biotech · Private company
R1 Therapeutics
Track this companyFree. Adds R1 Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- AP306 100 mg TIDPhase 2 · HyperphosphatemiaClinicalTrials.gov · fetched Nov 12, 2026
- AP306 125 mg BIDPhase 2 · HyperphosphatemiaClinicalTrials.gov · fetched Nov 12, 2026
- AP306 125 mg TIDPhase 2 · HyperphosphatemiaClinicalTrials.gov · fetched Nov 12, 2026
- AP306 150 mg BIDPhase 2 · HyperphosphatemiaClinicalTrials.gov · fetched Nov 12, 2026
- AP306 75 mg BIDPhase 2 · HyperphosphatemiaClinicalTrials.gov · fetched Nov 12, 2026
- AP306 75 mg TIDPhase 2 · HyperphosphatemiaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With HyperphosphatemiaPHASE2 · RECRUITING · started Jun 1, 2026ClinicalTrials.gov NCT06712654 · fetched Nov 12, 2026